CN1895434B - Medicine for treating hysteromyoma - Google Patents
Medicine for treating hysteromyoma Download PDFInfo
- Publication number
- CN1895434B CN1895434B CN200610010152A CN200610010152A CN1895434B CN 1895434 B CN1895434 B CN 1895434B CN 200610010152 A CN200610010152 A CN 200610010152A CN 200610010152 A CN200610010152 A CN 200610010152A CN 1895434 B CN1895434 B CN 1895434B
- Authority
- CN
- China
- Prior art keywords
- parts
- hysteromyoma
- medicine
- radix
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for treating hysteromyoma is prepared from 14 Chinese-medicinal materials including myrrh, Chinese angelica root, astragalus root, safflower, etc.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of gynaecopathia.
Background technology
Hysteromyoma (uterine myoma) is a modal benign tumor in the female sex organ, also is one of tumor common in the human body.Hysteromyoma is gynecological's frequently-occurring disease, and period of duration women sickness rate is about that 25%, 40～50 years old middle-aged women sickness rate is the highest to be about 50%～60%.The medicine of treatment hysteromyoma exists toxic and side effects big at present, and the course of treatment is long, the problem of weak curative effect.
Summary of the invention
The objective of the invention is for the medicine that solves present treatment hysteromyoma exists toxic and side effects big, the course of treatment is long, the problem of weak curative effect, and a kind of medicine for the treatment of hysteromyoma that provides.The medicine of treatment hysteromyoma is made by 12～18 parts of Squama Manis, 12～18 parts of Myrrhas, 8～12 parts of Rhizoma Corydalis, 18～22 parts of Radix Angelicae Sinensis, 12～18 parts of Rhizoma Atractylodis Macrocephalaes, 12～18 parts of Radixs Astragali, 12～18 parts of Radix Rehmanniaes Preparata, 12～18 parts of Flos Carthamis, 18～22 parts of Flos Loniceraes, 8～12 parts of Herba Houttuyniae, 12～18 parts of Oletum Trogopteroris, 8～12 portions of Folium Isatidiss, 8～12 portions of Radix Glycyrrhizaes, 12～18 parts of Herba Leonuris by ratio of weight and the number of copies.Medicine dosing of the present invention is few, and 21～30g takes medicine every day; Drug effect is fast, and 5～7 days uterus muscular tumors of taking medicine are just obviously dwindled, and the 10 days uterus muscular tumors of taking medicine narrow down to 2/3 of original volume.Medicine of the present invention has no side effect, good effect, and hysteromyoma treatment effective percentage is higher than 95%, and cure rate is greater than 70%.
Chinese crude drug Squama Manis of the present invention---function cures mainly: the routed carbuncle of detumescence, it is active to search wind, the stimulating milk secretion of stimulating the menstrual flow.It is swollen to control the carbuncle skin ulcer, anemofrigid-damp arthralgia, amenorrhea, galactostasis.The external hemostasis.
Myrrha---function cures mainly: the blood blood stasis removing that looses, subduing swelling and relieving pain.Control and fall damage, incised wound, muscles and bones, all Tong ， of trusted subordinate mass in the abdomen, amenorrhea, ulcer sore pain, anal fistula, diseases of the eye.
Rhizoma Corydalis---function cures mainly: invigorates blood circulation, and dissipating blood stasis; Regulate the flow of vital energy pain relieving.Control all pains of trusted subordinate's waist knee joint, menoxenia ， mass in the abdomen, metrorrhagia, puerperal blood faints, lochiorrhea, traumatic injury.
Radix Angelicae Sinensis---function cures mainly: benefiting blood and regulating blood circulation, menstruction regulating and pain relieving is moisturized laxation.Control menoxenia, amenorrhea stomachache ， mass in the abdomen knot is poly-, metrorrhagia; Headache due to deficiency of blood, dizzy, flaccidity syndrome and arthralgia syndrome; The dryness of the intestine dyschezia is heavy after the bloody dysentery; Ulcer sores, injury from falling down.
The Rhizoma Atractylodis Macrocephalae---function cures mainly: control treating swelling and pain by traumatic injury, fracture is sprained, rheumatalgia, laryngalgia.
The Radix Astragali (Radix Astragali)---function cures mainly: give birth to and use: benefit is defended consolidating superficial resistance, inducing diuresis to remove edema, poison holding, granulation promoting.Control spontaneous perspiration, night sweat, arthralgia due to stagnation of blood, edema, carbuncle are not burst or are burst and do not hold back for a long time.Moxibustion is used: invigorating the spleen and replenishing QI.Control the internal injury overstrain, diarrhea due to hypofunction of the spleen, proctoptosis, deficiency of vital energy blood prostration, metrorrhagia and leukorrhagia, and the card of all weakness of QI blood deficiency.
Radix Rehmanniae Preparata---function cures mainly: YIN nourishing, enrich blood.Control deficiency of YIN insufficiency of blood, the waist knee flaccidity, the chronic cough hectic fever due to YIN-deficiency, seminal emission, metrorrhagia, menoxenia is quenched one's thirst, frequency of micturition, deafness, blurred vision.
Flos Carthami---function cures mainly: promoting blood circulation to restore menstrual flow, blood stasis removing pain relieving.Control amenorrhea ， mass in the abdomen, difficult labour, stillborn fetus, disease that postpartum lochia can't go, congestion are had a pain, carbuncle, injury from falling down.
Flos Lonicerae---function cures mainly: heat clearing away, detoxifcation.Control the epidemic febrile disease heating, toxic-heat and blood stasis, carbuncle and ulcer, toxic swelling, scrofula, anal fistula.
Herba Houttuyniae---function cures mainly: heat-clearing and toxic substances removing, inducing diuresis to remove edema.Control pneumonia, lung abscess, hematodiarrhoea, malaria, edema, gonorrhea, leucorrhea, carbuncle, hemorrhoid, proctoptosis, eczema, tinea alba, scabies.
Oletum Trogopterori---function cures mainly: give birth to and use the promoting the circulation of blood pain relieving.Control all pains of trusted subordinate's vim and vigour, women's amenorrhea, puerperal, congestion was had a pain; External treatment Serpentis, scorpion, centipete bite.Fry with hemostasis.Control metrorrhagia, menorrhagia, leucorrhea with bloody discharge is without cease.
Folium Isatidis---function cures mainly: heat clearing away, detoxifcation, removing heat from blood, hemostasis.Control epidemic febrile disease intenseness of heat excessive thirst, influenza, acute infectious hepatitis, bacillary dysentery, acute gastroenteritis, acute pneumonia, erysipelas is spitted blood epistaxis, jaundice, dysentery, sore throat, aphtha, swollen ulcer drug.
Radix Glycyrrhizae---function cures mainly: and middle emergency, lung moistening, detoxifcation, coordinating the actions of various ingredients in a prescription.Moxibustion usefulness is controlled weakness of the spleen and stomach, lack of appetite, stomachache loose stool, overstrain heating, consumptive lung disease cough, cardiopalmus, infantile convulsion; Give birth to usefulness, control laryngopharynx swelling and pain, peptic ulcer, ulcer sores is separated poison of drug and alimentary toxicosis.
Herba Leonuri---function cures mainly: invigorates blood circulation, and blood stasis removing, regulating menstruation, water disappears.Control menoxenia, the vaginal bleeding during pregnancy difficult labour, retention of placenta, puerperal blood faints, abdominalgia with blood stasis, metrorrhagia and metrostaxis, hematuria is rushed down blood, the carbuncle skin infection.
The specific embodiment
The specific embodiment one: the medicine of present embodiment treatment hysteromyoma is made by 12～18 parts of Squama Manis, 12～18 parts of Myrrhas, 8～12 parts of Rhizoma Corydalis, 18～22 parts of Radix Angelicae Sinensis, 12～18 parts of Rhizoma Atractylodis Macrocephalaes, 12～18 parts of Radixs Astragali, 12～18 parts of Radix Rehmanniaes Preparata, 12～18 parts of Flos Carthamis, 18～22 parts of Flos Loniceraes, 8～12 parts of Herba Houttuyniae, 12～18 parts of Oletum Trogopteroris, 8～12 portions of Folium Isatidiss, 8～12 portions of Radix Glycyrrhizaes, 12～18 parts of Herba Leonuris by ratio of weight and the number of copies.
Present embodiment Chinese medicine raw material is ground into 100～200 purpose granules through after selecting, clean, drying, and is mixed by ratio of weight and the number of copies again; The medicine of treatment hysteromyoma can be made capsule, tablet or powder.
Table 1 is the clinical pharmacodynamics report of present embodiment treatment hysteromyoma.
Usage and dosage: take every day three times, take medicine 7～10g at every turn.Period in a medicine of the present invention is avoided eating anything raw or cold and maror.
The use present embodiment is treated the women at 30 27～50 years old age of example, and effective percentage is higher than 95%, and cure rate is greater than 70%.The effect of present embodiment treatment hysteromyoma is as shown in table 1, and wherein the B ultrasonic sheet that regular hospital provides is accepted and believed in state of an illness diagnosis.
Table 1
| Sequence number | Age | Disease | Hysteromyoma before the treatment (cm * cm) | Treatment time (my god) | Treatment back hysteromyoma (cm * cm) | Curative effect is judged |
| 1 | 35 | Hysteromyoma | 5.7×4.2 | 22 | 0 | Cure |
| 2 | 36 | Hysteromyoma | 6.3×5.0 | 10 | 4.3×3.9 | Effectively |
| 3 | 29 | Hysteromyoma | 3.2×2.1 | 24 | 0 | Cure |
| 4 | 30 | Hysteromyoma | 5.8×5.3 | 27 | 0 | Cure |
| Sequence number | Age | Disease | Hysteromyoma before the treatment (cm * cm) | Treatment time (my god) | Treatment back hysteromyoma (cm * cm) | Curative effect is judged |
| 5 | 33 | Hysteromyoma | 8.1×7.0 | 23 | 0 | Cure |
| 6 | 31 | Hysteromyoma | 7.3×6.8 | 20 | 2.3×2.0 | Effectively |
| 7 | 43 | Hysteromyoma | 5.3×4.6 | 26 | 0 | Cure |
| 8 | 49 | Hysteromyoma | 2.3×1.4 | 20 | 0 | Cure |
| 9 | 39 | Hysteromyoma | 3.4×3.1 | 22 | 0 | Cure |
| 10 | 46 | Hysteromyoma | 6.2×5.5 | 28 | 0 | Cure |
| 11 | 48 | Hysteromyoma | 6.4×5.9 | 25 | 2.3×1.7 | Effectively |
| 12 | 44 | Hysteromyoma | 7.9×7.5 | 30 | 0 | Cure |
| 13 | 33 | Hysteromyoma | 5.4×5.1 | 21 | 0 | Cure |
| 14 | 45 | Hysteromyoma | 6.1×5.7 | 24 | 0 | Cure |
| 15 | 48 | Hysteromyoma | 4.1×3.8 | 21 | 0 | Cure |
| 16 | 29 | Hysteromyoma | 3.7×3.4 | 26 | 0 | Cure |
| 17 | 46 | Hysteromyoma | 4.1×3.8 | 24 | 0 | Cure |
| 18 | 49 | Hysteromyoma | 4.0×3.7 | 26 | 0 | Cure |
| 19 | 37 | Hysteromyoma | 6.3×5.7 | 25 | 2.7×2.2 | Effectively |
| 20 | 36 | Hysteromyoma | 5.5×5.0 | 23 | 0 | Cure |
| 21 | 50 | Hysteromyoma | 7.1×7.0 | 20 | 0 | Cure |
| 22 | 32 | Hysteromyoma | 4.1×3.3 | 20 | 0 | Cure |
| 23 | 27 | Hysteromyoma | 5.0×4.7 | 29 | 0 | Cure |
| 24 | 36 | Hysteromyoma | 3.1×3.0 | 27 | 0 | Cure |
| 25 | 38 | Hysteromyoma | 4.3×3.8 | 30 | 4.3×3.8 | Invalid |
| Sequence number | Age | Disease | Hysteromyoma before the treatment (cm * cm) | Treatment time (my god) | Treatment back hysteromyoma (cm * cm) | Curative effect is judged |
| 26 | 31 | Hysteromyoma | 5.1×4.5 | 25 | 1.2×0.8 | Effectively |
| 27 | 35 | Hysteromyoma | 3.7×3.3 | 24 | 0 | Cure |
| 28 | 45 | Hysteromyoma | 2.3×1.5 | 15 | 0 | Cure |
| 29 | 39 | Hysteromyoma | 5.4×5.0 | 25 | 0 | Cure |
| 30 | 35 | Hysteromyoma | 2.0×1.8 | 21 | 0 | Cure |
Present embodiment treatment time short (20～30 days), the cure rate height has been exempted patient hardship of operating on and the risk of performing the operation, and expense is lower by 25%～35% than operation, has alleviated patient's financial burden.
The specific embodiment two: the difference of the present embodiment and the specific embodiment one is: the medicine of treatment hysteromyoma is made by 13～17 parts of Squama Manis, 13～17 parts of Myrrhas, 9～11 parts of Rhizoma Corydalis, 19～21 parts of Radix Angelicae Sinensis, 13～17 parts of Rhizoma Atractylodis Macrocephalaes, 13～17 parts of Radixs Astragali, 13～17 parts of Radix Rehmanniaes Preparata, 13～17 parts of Flos Carthamis, 19～21 parts of Flos Loniceraes, 9～11 parts of Herba Houttuyniae, 13～17 parts of Oletum Trogopteroris, 9～11 portions of Folium Isatidiss, 9～11 portions of Radix Glycyrrhizaes, 13～17 parts of Herba Leonuris by ratio of weight and the number of copies.
The specific embodiment three: the difference of the present embodiment and the specific embodiment one is: the medicine of treatment hysteromyoma is made by 15 parts of Squama Manis, 15 parts of Myrrhas, 10 parts of Rhizoma Corydalis, 20 parts of Radix Angelicae Sinensis, 15 parts of Rhizoma Atractylodis Macrocephalaes, 15 parts of Radixs Astragali, 15 parts of Radix Rehmanniaes Preparata, 15 parts of Flos Carthamis, 20 parts of Flos Loniceraes, 10 parts of Herba Houttuyniae, 15 parts of Oletum Trogopteroris, 10 portions of Folium Isatidiss, 10 portions of Radix Glycyrrhizaes, 15 parts of Herba Leonuris by ratio of weight and the number of copies.
Claims (3)
1. a medicine for the treatment of hysteromyoma is characterized in that being made by 12～18 parts of Squama Manis, 12～18 parts of Myrrhas, 8～12 parts of Rhizoma Corydalis, 18～22 parts of Radix Angelicae Sinensis, 12～18 parts of Rhizoma Atractylodis Macrocephalaes, 12～18 parts of Radixs Astragali, 12～18 parts of Radix Rehmanniaes Preparata, 12～18 parts of Flos Carthamis, 18～22 parts of Flos Loniceraes, 8～12 parts of Herba Houttuyniae, 12～18 parts of Oletum Trogopteroris, 8～12 portions of Folium Isatidiss, 8～12 portions of Radix Glycyrrhizaes, 12～18 parts of Herba Leonuris by ratio of weight and the number of copies.
2. a kind of medicine for the treatment of hysteromyoma according to claim 1 is characterized in that being made by 13～17 parts of Squama Manis, 13～17 parts of Myrrhas, 9～11 parts of Rhizoma Corydalis, 19～21 parts of Radix Angelicae Sinensis, 13～17 parts of Rhizoma Atractylodis Macrocephalaes, 13～17 parts of Radixs Astragali, 13～17 parts of Radix Rehmanniaes Preparata, 13～17 parts of Flos Carthamis, 19～21 parts of Flos Loniceraes, 9～11 parts of Herba Houttuyniae, 13～17 parts of Oletum Trogopteroris, 9～11 portions of Folium Isatidiss, 9～11 portions of Radix Glycyrrhizaes, 13～17 parts of Herba Leonuris by ratio of weight and the number of copies.
3. a kind of medicine for the treatment of hysteromyoma according to claim 1 is characterized in that being made by 15 parts of Squama Manis, 15 parts of Myrrhas, 10 parts of Rhizoma Corydalis, 20 parts of Radix Angelicae Sinensis, 15 parts of Rhizoma Atractylodis Macrocephalaes, 15 parts of Radixs Astragali, 15 parts of Radix Rehmanniaes Preparata, 15 parts of Flos Carthamis, 20 parts of Flos Loniceraes, 10 parts of Herba Houttuyniae, 15 parts of Oletum Trogopteroris, 10 portions of Folium Isatidiss, 10 portions of Radix Glycyrrhizaes, 15 parts of Herba Leonuris by ratio of weight and the number of copies.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200610010152A CN1895434B (en) | 2006-06-14 | 2006-06-14 | Medicine for treating hysteromyoma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200610010152A CN1895434B (en) | 2006-06-14 | 2006-06-14 | Medicine for treating hysteromyoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1895434A CN1895434A (en) | 2007-01-17 |
| CN1895434B true CN1895434B (en) | 2010-05-12 |
Family
ID=37608174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200610010152A Expired - Fee Related CN1895434B (en) | 2006-06-14 | 2006-06-14 | Medicine for treating hysteromyoma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1895434B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101579508B (en) * | 2009-03-23 | 2011-08-24 | 路正平 | Medicine for treating hyperplasia of mammary glands and preparation method thereof |
| CN102648945A (en) * | 2011-02-28 | 2012-08-29 | 刘树平 | Chinese medicinal formula for treating hysteromyoma |
| CN104288398A (en) * | 2014-09-29 | 2015-01-21 | 解淑琼 | Traditional Chinese medicine for treating uterine fibroid with syndrome of stagnation and congelation of phlegm-damp and preparation method thereof |
| CN107308416A (en) * | 2017-07-11 | 2017-11-03 | 姚惠琴 | A kind of Chinese medicine composition for treating fibroid |
| CN108607055A (en) * | 2018-07-12 | 2018-10-02 | 农星谦 | Treat carcinoid Chinese medicine composition in uterus and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1095610A (en) * | 1993-05-24 | 1994-11-30 | 潘世庆 | The pharmaceutical preparation Fubingkang of treatment, prevention gynecological diseases |
| CN1500501A (en) * | 2002-11-12 | 2004-06-02 | 王红波 | Compound traditional Chinese medicine formulation for curing hysteromyoma |
-
2006
- 2006-06-14 CN CN200610010152A patent/CN1895434B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1095610A (en) * | 1993-05-24 | 1994-11-30 | 潘世庆 | The pharmaceutical preparation Fubingkang of treatment, prevention gynecological diseases |
| CN1500501A (en) * | 2002-11-12 | 2004-06-02 | 王红波 | Compound traditional Chinese medicine formulation for curing hysteromyoma |
Non-Patent Citations (4)
| Title |
|---|
| 蔡玉华等.子宫肌瘤的中医药治疗及研究现状.中国中医药信息杂志6 10.1999,6(10),19-22. |
| 蔡玉华等.子宫肌瘤的中医药治疗及研究现状.中国中医药信息杂志6 10.1999,6(10),19-22. * |
| 陈敏等.子宫肌瘤病因病机及其证治集要.中医药学刊21 6.2003,21(6),1002-1004. |
| 陈敏等.子宫肌瘤病因病机及其证治集要.中医药学刊21 6.2003,21(6),1002-1004. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1895434A (en) | 2007-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102151325B (en) | Traditional Chinese medicine for treating breast diseases | |
| CN101926961B (en) | Oral Chinese medicinal composition for treating pelvic inflammatory disease | |
| CN104147514A (en) | Chinese medicinal composition for treating cervical spondylosis and preparation method thereof | |
| CN104173509A (en) | Moxa stick for treating dysmenorrhea | |
| CN1895434B (en) | Medicine for treating hysteromyoma | |
| CN104306944A (en) | Oral medicine for treating varicosities | |
| CN104922633A (en) | Traditional Chinese medicine composition for treating arthralgia as well as preparation method and application method thereof | |
| CN102895447A (en) | Chinese medicinal ointment for treating orthopaedic diseases and preparation method thereof | |
| CN103908511B (en) | One treats chondromatous Chinese medicinal pill and preparation method | |
| CN101569738A (en) | Plaster for treating mastitis, hyperplasia of mammary glands, breast lumps, join thydrops, traumatic injury, preparation method and application thereof | |
| CN102552862A (en) | Preparation method of traditional Chinese medicine for treatment of yang deficiency, qi stagnation and blood stasis type chronic pelvic inflammatory disease | |
| CN104587206A (en) | Medicament for treating bedsore and preparation method of medicament | |
| CN101912502B (en) | Traditional Chinese medicine for treating acute urethrocystitis | |
| CN104225487A (en) | Traditional Chinese medicine for treating lumbar hyperosteogeny | |
| CN104189787A (en) | Capsule preparation for effectively treating pelvic inflammation | |
| CN105687589A (en) | Chinese medicine for treating clinical wound and preparation method | |
| CN100371016C (en) | Chinese traditional medicine preparation for curing mastopathy in installments | |
| CN104491670A (en) | Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease | |
| CN103877489A (en) | Medicine for treating bedsore | |
| CN103356797A (en) | Chinese medicine composition for treating kidney stone | |
| CN102512635B (en) | Chinese medicine mixture and application thereof and preparing method of Chinese medicine composition and Chinese medicine mixture | |
| CN102670925A (en) | Medicament for treating irregular menstruation and preparation method thereof | |
| CN101869629B (en) | Traditional Chinese medicine for treating renal calculus | |
| CN105617103A (en) | Nursing cleaning liquid medicine for treating pelvic inflammation and preparation method | |
| CN104491719A (en) | Traditional Chinese medicine composition for treating cervical cancers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100512 Termination date: 20130614 |